| Eman Mohamed Mohamed, | |
|
6564 Ellwell Cres, Rego Park, NY 11374-5032 | |
| (347) 459-6239 | |
| Not Available |
| Full Name | Eman Mohamed Mohamed |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 6564 Ellwell Cres, Rego Park, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124732409 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 049945 (New York) | Primary |
| Provider Name | Core Care Pt Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1841862349 PECOS PAC ID: 2264836261 Enrollment ID: O20210813000354 |
News Archive
The St. Petersburg-Times: Three complaints by whistleblowers suing WellCare Health Plans Inc. have been unsealed in recent days as part of a federal probe into the company's operations. Federal officials raided the company offices in 2007. In the most recent complaints, "Clark J. Bolton, a former supervisor of special investigations at WellCare, said the insurer encouraged overbilling and refused to audit claims for fraud in order to curry favor with doctors and hospitals and build market share.
That midday wall you hit where you just can't stay awake may be an indicator of obstructed nasal passages and sleep-disordered breathing, according to a new study published in the October 2007 edition of Otolaryngology – Head and Neck Surgery .
Cincinnati Cancer Center (CCC) and UC Cancer Institute researchers have found that a vaccine, targeting tumors that produce a certain protein and receptor responsible for communication between cells and the body's immune system, could initiate the immune response to fight cancer.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today stated that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on January 20, 2010 to discuss the New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eman Mohamed Mohamed, 6564 Ellwell Cres, Rego Park, NY 11374-5032 Ph: (347) 459-6239 | Eman Mohamed Mohamed, 6564 Ellwell Cres, Rego Park, NY 11374-5032 Ph: (347) 459-6239 |
News Archive
The St. Petersburg-Times: Three complaints by whistleblowers suing WellCare Health Plans Inc. have been unsealed in recent days as part of a federal probe into the company's operations. Federal officials raided the company offices in 2007. In the most recent complaints, "Clark J. Bolton, a former supervisor of special investigations at WellCare, said the insurer encouraged overbilling and refused to audit claims for fraud in order to curry favor with doctors and hospitals and build market share.
That midday wall you hit where you just can't stay awake may be an indicator of obstructed nasal passages and sleep-disordered breathing, according to a new study published in the October 2007 edition of Otolaryngology – Head and Neck Surgery .
Cincinnati Cancer Center (CCC) and UC Cancer Institute researchers have found that a vaccine, targeting tumors that produce a certain protein and receptor responsible for communication between cells and the body's immune system, could initiate the immune response to fight cancer.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today stated that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on January 20, 2010 to discuss the New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
› Verified 7 days ago
Mr. Nino Pompeyo Rocco Altamirano Borja, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 6241 Woodhaven Blvd, Rego Park, NY 11374 Phone: 929-607-3271 Fax: 929-607-3267 | |
Nypt Rehab Services Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6607 Alderton St, Rego Park, NY 11374 Phone: 718-275-7790 Fax: 718-358-3837 | |
Lichieh Pao, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 6541 Wetherole St, Rego Park, NY 11374 Phone: 917-862-7787 | |
Mikaela Adriano Lagman, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 98120 Queens Blvd Ste 1lm, Rego Park, NY 11374 Phone: 718-897-3333 Fax: 718-997-0342 | |
Ralph Arden Paul Fuster Murillo, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6288 Austin St, Rego Park, NY 11374 Phone: 718-314-5849 | |
Rhyan Fermin Florendo, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9748 64th Ave Fl 2, Rego Park, NY 11374 Phone: 510-367-7730 | |
Stephanie Patricia Siry, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6601 Burns St Apt 6y, Rego Park, NY 11374 Phone: 646-418-9513 |